Global Mouse EGF Protein Market Growth (Status and Outlook) 2025-2031
Description
The global Mouse EGF Protein market size is predicted to grow from US$ 100 million in 2025 to US$ 186 million in 2031; it is expected to grow at a CAGR of 10.9% from 2025 to 2031.
Epidermal growth factor (EGF) is a small, potent growth factor that induces cell proliferation, differentiation, and survival. EGF is the founding member of the EGF family, which also includes TGF-alpha, amphiregulin (AR), betacellulin (BTC), epiregulin (EPR), heparin-binding EGF-like growth factor (HB EGF), epidermal factor, and neuregulin (NRG)-1 to -6. EGF family members are characterized by a common structural motif, the EGF-like domain, which contains three intramolecular disulfide bonds formed by six similarly spaced, conserved cysteine residues. These disulfide bonds are essential for proper protein conformation and receptor binding.
United States market for Mouse EGF Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Mouse EGF Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Mouse EGF Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Mouse EGF Protein players cover Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Mouse EGF Protein Industry Forecast” looks at past sales and reviews total world Mouse EGF Protein sales in 2024, providing a comprehensive analysis by region and market sector of projected Mouse EGF Protein sales for 2025 through 2031. With Mouse EGF Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mouse EGF Protein industry.
This Insight Report provides a comprehensive analysis of the global Mouse EGF Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mouse EGF Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mouse EGF Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mouse EGF Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mouse EGF Protein.
This report presents a comprehensive overview, market shares, and growth opportunities of Mouse EGF Protein market by product type, application, key players and key regions and countries.
Segmentation by Type:
Purity＞95%
Purity≤95%
Segmentation by Application:
Biological Laboratories
University
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Amgen
Betta Pharmaceuticals
Thermo Fisher Scientific Inc.
Eli Lilly and Company
Bio-Techne
Merck
Yeasen
Sino Biological
Miltenyi Biotec
Proteintech
BioLegend
Please note: The report will take approximately 2 business days to prepare and deliver.
Epidermal growth factor (EGF) is a small, potent growth factor that induces cell proliferation, differentiation, and survival. EGF is the founding member of the EGF family, which also includes TGF-alpha, amphiregulin (AR), betacellulin (BTC), epiregulin (EPR), heparin-binding EGF-like growth factor (HB EGF), epidermal factor, and neuregulin (NRG)-1 to -6. EGF family members are characterized by a common structural motif, the EGF-like domain, which contains three intramolecular disulfide bonds formed by six similarly spaced, conserved cysteine residues. These disulfide bonds are essential for proper protein conformation and receptor binding.
United States market for Mouse EGF Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Mouse EGF Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Mouse EGF Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Mouse EGF Protein players cover Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Mouse EGF Protein Industry Forecast” looks at past sales and reviews total world Mouse EGF Protein sales in 2024, providing a comprehensive analysis by region and market sector of projected Mouse EGF Protein sales for 2025 through 2031. With Mouse EGF Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mouse EGF Protein industry.
This Insight Report provides a comprehensive analysis of the global Mouse EGF Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mouse EGF Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mouse EGF Protein market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mouse EGF Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mouse EGF Protein.
This report presents a comprehensive overview, market shares, and growth opportunities of Mouse EGF Protein market by product type, application, key players and key regions and countries.
Segmentation by Type:
Purity＞95%
Purity≤95%
Segmentation by Application:
Biological Laboratories
University
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Amgen
Betta Pharmaceuticals
Thermo Fisher Scientific Inc.
Eli Lilly and Company
Bio-Techne
Merck
Yeasen
Sino Biological
Miltenyi Biotec
Proteintech
BioLegend
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
120 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Mouse EGF Protein Market Size by Player
- 4 Mouse EGF Protein by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Mouse EGF Protein Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
